Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...

The drug was 88% effective against the need for medical attention among those in their second respiratory virus season.

Some Alberta doctors are calling on the provincial government to make an injection designed to protect newborns from severe ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Multinational medical companies reached collaborations with local healthcare authorities, hospitals and businesses at the ongoing 7th China International Import Expo held in Shanghai to jointly build ...

Overall, 44.6 percent of 866 women with an infant born during August 2023 to March 2024 reported infant receipt of nirsevimab ...

This collaboration came after Nirsevimab injection, the world’s first broadly protective option against RSV designed for infants, was approved for marketing in China in December. Several regions ...

Some provinces have begun rolling out a vaccination program for infants with newly authorized products. The situation is much ...

Infants will be able to receive a free immunisation to protect them against serious illness from respiratory syncytial virus (RSV), under a new $16.6 million NSW Government RSV prevention program to ...

A Winnipeg mother with a newborn is pleading with the province to start offering RSV shots to all babies. As we navigate ...

Provider recommendation for maternal vaccination or infant nirsevimab linked to higher immunization coverage. HealthDay News — In the 2023 to 2024 respiratory syncytial virus (RSV) season ...

MemorialCare Miller Children's & Women's Hospital Long Beach has been recognized by the California Department of Public ...